Alberto Ferreira

2.1k total citations · 1 hit paper
27 papers, 1.5k citations indexed

About

Alberto Ferreira is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Alberto Ferreira has authored 27 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Ophthalmology, 11 papers in Radiology, Nuclear Medicine and Imaging and 5 papers in Molecular Biology. Recurrent topics in Alberto Ferreira's work include Retinal Diseases and Treatments (15 papers), Retinal Imaging and Analysis (9 papers) and Retinal and Optic Conditions (8 papers). Alberto Ferreira is often cited by papers focused on Retinal Diseases and Treatments (15 papers), Retinal Imaging and Analysis (9 papers) and Retinal and Optic Conditions (8 papers). Alberto Ferreira collaborates with scholars based in Switzerland, United Kingdom and United States. Alberto Ferreira's co-authors include Tien Yin Wong, Paul Mitchell, Christian Roux, Peter Mesenbrink, Chak Sing Lau, Florian Hartl, Jean‐Yves Reginster, Kenneth G. Saag, P. Papanastasiou and David M. Reid and has published in prestigious journals such as The Lancet, PLoS ONE and Biometrics.

In The Last Decade

Alberto Ferreira

27 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Epidemiology and Disease Burden of Pathologic Myopia and Myopic Choroidal Neovascularization: An Evidence-Based Systematic Review

2013 519 citations Tien Yin Wong, Alberto Ferreira et al. American Journal of Ophthalmology profile →

Peers

Countries citing papers authored by Alberto Ferreira

Since Specialization

Citations

This map shows the geographic impact of Alberto Ferreira's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alberto Ferreira with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alberto Ferreira more than expected).

Fields of papers citing papers by Alberto Ferreira

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alberto Ferreira. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alberto Ferreira. The network helps show where Alberto Ferreira may publish in the future.

Co-authorship network of co-authors of Alberto Ferreira

This figure shows the co-authorship network connecting the top 25 collaborators of Alberto Ferreira. A scholar is included among the top collaborators of Alberto Ferreira based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alberto Ferreira. Alberto Ferreira is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Resource Utilization Among Glaucoma Patients in the UK Treated with Beta-Blocker and Non-Beta-Blocker Adjunctive Therapy: A Retrospective Cohort Analysis 2017 ·Advances in Therapy ·Ananth C. Viswanathan, (unknown), (unknown), David Covert, (unknown), (unknown), (unknown), Alberto Ferreira	3
2	A Retrospective Study of Ranibizumab Treatment Regimens for Neovascular Age-Related Macular Degeneration (nAMD) in Australia and the United Kingdom 2017 ·Advances in Therapy ·Robert L. Johnston, (unknown), (unknown), Alberto Ferreira, (unknown), Paul Mitchell	36
3	Development of a new Rasch-based scoring algorithm for the National Eye Institute Visual Functioning Questionnaire to improve its interpretability 2017 ·Health and Quality of Life Outcomes ·Jennifer Petrillo, Neil M. Bressler, Ecosse L. Lamoureux, Alberto Ferreira, Stefan Cano	28
4	The Clinical Effectiveness of Ranibizumab Treat and Extend Regimen in nAMD: Systematic Review and Network Meta-Analysis 2017 ·Advances in Therapy ·(unknown), Julie Glanville, Rachael McCool, Alberto Ferreira, (unknown), Ruth Pulikottil-Jacob	20
5	Severe Ocular Inflammation Following Ranibizumab or Aflibercept Injections for Age-Related Macular Degeneration: A Retrospective Claims Database Analysis 2016 ·Ophthalmic Epidemiology ·Eric H. Souied, Pravin U. Dugel, Alberto Ferreira, (unknown), Jingsong Lu, Simon P. Kelly	48
6	Cost-effectiveness of ranibizumab in the treatment of visual impairment due to diabetic macular edema 2016 ·Journal of Medical Economics ·(unknown), M Barbeau, Alberto Ferreira	12
7	Treatment Frequency and Dosing Interval of Ranibizumab and Aflibercept for Neovascular Age-Related Macular Degeneration in Routine Clinical Practice in the USA 2015 ·PLoS ONE ·Alberto Ferreira, Alexandros Sagkriotis, Melvin Olson, Jingsong Lu, Charles Makin, (unknown)	51
8	Indirect comparisons of ranibizumab and dexamethasone in macular oedema secondary to retinal vein occlusion 2014 ·BMC Medical Research Methodology ·Howard Thom, Gorana Capkun, Richard M. Nixon, Alberto Ferreira	8
9	A United Kingdom-based economic evaluation of ranibizumab for patients with retinal vein occlusion (RVO) 2014 ·Journal of Medical Economics ·Matthew Taylor, (unknown), Alberto Ferreira, Kerry Gairy, (unknown), Julie Blouin, Paul Mitchell	10
10	Efficacy and safety of widely used treatments for macular oedema secondary to retinal vein occlusion: a systematic review 2014 ·BMC Ophthalmology ·Julie Glanville, Jacoby Patterson, Rachael McCool, Alberto Ferreira, Kerry Gairy, Ian Pearce	47
11	Mapping the 25-item National Eye Institute Visual Functioning Questionnaire (NEI VFQ-25) to EQ-5D Utility Scores 2014 ·Ophthalmic Epidemiology ·Stephen Kay, Alberto Ferreira	32
12	Estimated Cases of Blindness and Visual Impairment from Neovascular Age-Related Macular Degeneration Avoided in Australia by Ranibizumab Treatment 2014 ·PLoS ONE ·Paul Mitchell, Neil M. Bressler, Quan V. Doan, Chantal Dolan, Alberto Ferreira, Aaron Osborne, Elena Rochtchina, Mark D. Danese, Shoshana Colman, Tien Yin Wong	40
13	Epidemiology and Disease Burden of Pathologic Myopia and Myopic Choroidal Neovascularization: An Evidence-Based Systematic Review breakdown → 2013 ·American Journal of Ophthalmology ·Tien Yin Wong, Alberto Ferreira, (unknown), (unknown), Paul Mitchell	519
14	Health state utilities in patients with diabetic retinopathy, diabetic macular oedema and age-related macular degeneration: a systematic review 2013 ·BMC Ophthalmology ·Edith Poku, John Brazier, Jill Carlton, Alberto Ferreira	26
15	Sustained remission of symptoms and improved health-related quality of life in patients with cryopyrin-associated periodic syndrome treated with canakinumab: results of a double-blind placebo-controlled randomized withdrawal study 2011 ·Arthritis Research & Therapy ·Isabelle Koné‐Paut, Helen J. Lachmann, Jasmin Kuemmerle‐Deschner, É. Hachulla, Kieron Leslie, Richard Mouy, Alberto Ferreira, K. Lheritier, Neha Patel, Ralph Preiss, Philip N. Hawkins	103
16	Organ Dysfunction: General Approach, Epidemiology, and Organ Failure Scores 2011 ·Seminars in Respiratory and Critical Care Medicine ·Alberto Ferreira, Yasser Sakr	34
17	Zoledronic Acid and Risedronate in the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis (Health Outcomes and Reduced Incidence With Zoledronic Acid Once Yearly Trial): A Multicentre, Double-Blind, Double-Dummy, Randomized Controlled Trial 2009 ·Obstetrical & Gynecological Survey ·David M. Reid, Jean‐Pierre Devogelaer, Kenneth G. Saag, Christian Roux, Chak Sing Lau, Jean‐Yves Reginster, P. Papanastasiou, Alberto Ferreira, Florian Hartl, T. Fashola, Peter Mesenbrink, Philip N. Sambrook	1
18	Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomised controlled trial 2009 ·The Lancet ·David M. Reid, Jean‐Pierre Devogelaer, Kenneth G. Saag, Christian Roux, Chak Sing Lau, Jean‐Yves Reginster, P. Papanastasiou, Alberto Ferreira, Florian Hartl, T. Fashola, Peter Mesenbrink, Philip N. Sambrook	366
19	A New Approach to Modeling Daily Probabilities of Conception 1999 ·Biometrics ·Patrick Royston, Alberto Ferreira	22
20	Bom senso e bom gosto : a questão Coimbrã 1968 ·Alberto Ferreira, (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact